These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7571189

  • 1. Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure.
    Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T.
    Urol Int; 1995; 55(1):6-10. PubMed ID: 7571189
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone.
    Umekawa T, Kohri K, Kurita T, Hirota S, Nomura S, Kitamura Y.
    Biochem Mol Biol Int; 1995 Jan; 35(1):223-30. PubMed ID: 7735136
    [Abstract] [Full Text] [Related]

  • 3. Structure and expression of the mRNA encoding urinary stone protein (osteopontin).
    Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H.
    J Biol Chem; 1993 Jul 15; 268(20):15180-4. PubMed ID: 8325891
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of female sex hormones on urinary stone formation in rats.
    Iguchi M, Takamura C, Umekawa T, Kurita T, Kohri K.
    Kidney Int; 1999 Aug 15; 56(2):479-85. PubMed ID: 10432386
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the expression of OPN mRNA in the rat as an experimental model of renal stone disease.
    Amasaki N, Yamate T, Umekawa T, Ishikawa Y, Kajikawa H, Kurita T.
    Int J Urol; 1996 Jan 15; 3(1 Suppl):S88-91. PubMed ID: 24449951
    [Abstract] [Full Text] [Related]

  • 6. Expression of osteopontin mRNA in normal and stone-forming rat kidney.
    Jiang XJ, Feng T, Chang LS, Kong XT, Wang G, Zhang ZW, Guo YL.
    Urol Res; 1998 Jan 15; 26(6):389-94. PubMed ID: 9879818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T, Sato M, Fujita K, Tozawa K, Nomura S, Kohri K.
    Urol Res; 2001 Feb 15; 29(1):50-6. PubMed ID: 11310216
    [Abstract] [Full Text] [Related]

  • 9. Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat.
    Verstrepen WA, Persy VP, Verhulst A, Dauwe S, De Broe ME.
    Nephrol Dial Transplant; 2001 Apr 15; 16(4):712-24. PubMed ID: 11274264
    [Abstract] [Full Text] [Related]

  • 10. Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney.
    Yasui T, Fujita K, Sasaki S, Iguchi M, Hirota S, Nomura S, Azuma Y, Ohta T, Kohri K.
    Urol Res; 1998 Apr 15; 26(5):355-60. PubMed ID: 9840346
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
    Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT.
    Lab Invest; 1993 Sep 15; 69(3):355-63. PubMed ID: 8377476
    [Abstract] [Full Text] [Related]

  • 12. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T, Fujita K, Sato M, Sugimoto M, Iguchi M, Nomura S, Kohri K.
    Urol Res; 1999 Jun 15; 27(3):194-9. PubMed ID: 10422821
    [Abstract] [Full Text] [Related]

  • 13. Regulation of osteopontin expression in a rat model of urolithiasis.
    Chang L, Feng T, Li J, Dou C, Wei J, Guo Y.
    Chin Med J (Engl); 2001 Aug 15; 114(8):829-32. PubMed ID: 11780360
    [Abstract] [Full Text] [Related]

  • 14. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis.
    Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC.
    Kidney Int; 1998 Jan 15; 53(1):136-45. PubMed ID: 9453010
    [Abstract] [Full Text] [Related]

  • 15. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.
    Vernon HJ, Osborne C, Tzortzaki EG, Yang M, Chen J, Rittling SR, Denhardt DT, Buyske S, Bledsoe SB, Evan AP, Fairbanks L, Simmonds HA, Tischfield JA, Sahota A.
    Kidney Int; 2005 Sep 15; 68(3):938-47. PubMed ID: 16105024
    [Abstract] [Full Text] [Related]

  • 16. Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption.
    Chen J, Singh K, Mukherjee BB, Sodek J.
    Matrix; 1993 Mar 15; 13(2):113-23. PubMed ID: 8492741
    [Abstract] [Full Text] [Related]

  • 17. Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process.
    Xie Y, Nishi S, Iguchi S, Imai N, Sakatsume M, Saito A, Ikegame M, Iino N, Shimada H, Ueno M, Kawashima H, Arakawa M, Gejyo F.
    Kidney Int; 2001 Mar 15; 59(3):959-74. PubMed ID: 11231351
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD, Nanci A, Khan SR.
    J Bone Miner Res; 1995 Dec 15; 10(12):1913-29. PubMed ID: 8619372
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
    Yu XQ, Wu LL, Huang XR, Yang N, Gilbert RE, Cooper ME, Johnson RJ, Lai KN, Lan HY.
    Kidney Int; 2000 Oct 15; 58(4):1469-80. PubMed ID: 11012882
    [Abstract] [Full Text] [Related]

  • 20. Variable in vivo regulation of rat vitamin D-dependent genes (osteopontin, Ca,Mg-adenosine triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): implications for differing mechanisms of regulation and involvement of multiple factors.
    Matkovits T, Christakos S.
    Endocrinology; 1995 Sep 15; 136(9):3971-82. PubMed ID: 7649106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.